ADMA Biologics, Inc.ADMANASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank69
3Y CAGR-38.2%
5Y CAGR-2.1%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-38.2%/yr
Quarterly compound
5Y CAGR
-2.1%/yr
Recent deceleration
Percentile
P69
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 10.99% |
| Q3 2025 | 9.56% |
| Q2 2025 | 5.03% |
| Q1 2025 | 6.39% |
| Q4 2024 | 49.32% |
| Q3 2024 | 22.04% |
| Q2 2024 | 20.62% |
| Q1 2024 | 12.24% |
| Q4 2023 | -10.99% |
| Q3 2023 | 2.00% |
| Q2 2023 | 0.42% |
| Q1 2023 | -12.40% |
| Q4 2022 | 46.58% |
| Q3 2022 | -12.27% |
| Q2 2022 | -10.09% |
| Q1 2022 | -17.00% |
| Q4 2021 | 1.62% |
| Q3 2021 | -13.22% |
| Q2 2021 | -8.97% |
| Q1 2021 | 6.50% |
| Q4 2020 | 12.22% |
| Q3 2020 | -8.59% |
| Q2 2020 | -31.81% |
| Q1 2020 | 195.69% |
| Q4 2019 | -27.48% |
| Q3 2019 | -32.23% |
| Q2 2019 | 314.85% |
| Q1 2019 | -49.22% |
| Q4 2018 | -46.87% |
| Q3 2018 | -33.76% |
| Q2 2018 | 138.50% |
| Q1 2018 | -42.91% |
| Q4 2017 | 76.67% |
| Q3 2017 | -70.11% |
| Q2 2017 | 301.85% |
| Q1 2017 | -141.37% |
| Q4 2016 | -2829.71% |
| Q3 2016 | -103.65% |
| Q2 2016 | 202.70% |
| Q1 2016 | -497.48% |